Growing Optimism About ProQR Therapeutics (PRQR)’s RNA Editing Platform and Future Clinical Catalysts
As of March 19, 2026, analysts remain confident in ProQR Therapeutics N.V. (NASDAQ:PRQR), with 100% maintaining “Buy” ratings.
Proqr Therapeutics N.v. (PRQR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Adage Capital Management Phill Gross And Robert Atchinson | 6,253,467 | $10,130,617 | 0.02% | |
| 2. | Sio Capital Michael Castor | 1,954,715 | $3,166,638 | -10% | 0.45% |
| 3. | DAFNA Capital Management Nathan Fischel | 1,567,561 | $2,539,449 | 0.58% | |
| 4. | Kynam Capital Derrick Tang | 1,566,317 | $2,537,434 | 0.16% | |
| 5. | Ikarian Capital Neil Shahrestani | 1,492,229 | $2,417,411 | 0.2% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.72 | 150,000 | $257,925.00 | 300,000 | 2026-07-17 | Filing | |
| $1.74 | 150,000 | $261,000.00 | 300,000 | 2026-07-09 | Filing | |
| $1.59 | 150,000 | $238,500.00 | 150,000 | 2026-07-07 | Filing | |
| $1.54 | 150,000 | $231,000.00 | 150,000 | 2026-06-26 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 150,000 | $279,000 | 0.02% | |
| 2. | 64,000 | $119,040 | 0% | |
| 3. | 25,000 | $46,500 | 0% | |
| 4. | 12,500 | $23,250 | 0% | |
| 5. | 10,500 | $19,530 | 0.01% |
News See All
Top 10 Stocks Under $5 That Could Triple
At one end of the spectrum, until a few weeks ago, there was optimism about the broader market's performance this year.
Were Hedge Funds Right About ProQR Therapeutics NV (PRQR)?
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting period.
Hedge Funds Are Selling ProQR Therapeutics NV (PRQR)
We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September...
Hedge Funds Souring On ProQR Therapeutics NV (PRQR)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Drop The Ball On ProQR Therapeutics NV (PRQR) ?
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could make for a good addition...
Were Hedge Funds Right About Dumping ProQR Therapeutics NV (PRQR)?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Here's What Hedge Funds Think About ProQR Therapeutics NV (PRQR)
Insider Monkey finished processing more than 738 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of March 31st, 2019.
Here is What Hedge Funds Think About ProQR Therapeutics NV (PRQR)
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Is ProQR Therapeutics NV (PRQR) Going to Burn These Hedge Funds?
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved, lost a third of its value since the end of July.
Hedge Fund Resource Center